Viewing Study NCT05264493

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:03 AM
Ignite Modification Date: 2026-02-03 @ 4:38 PM
Study NCT ID: NCT05264493
Status: COMPLETED
Last Update Posted: 2022-03-03
First Post: 2022-02-14
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Bioavailability Study of Naloxone 5 Milligrams (mg) Intramuscular (IM) Autoinjector
Sponsor: Pfizer
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy Volunteers View
Keywords:

Keywords

Keyword Brief Keyword Text View
None naloxone View
None autoinjector View
None intramuscular View
None high dose View
None 5 mg View
None healthy volunteers View
None safety View
None cross-over study View
None pharmacokinetics View
None 3 treatment arms View